FIELD: medicine. SUBSTANCE: method involves applying basic therapy with sugar- reducing preparations. Peptide bioregulators complex is concurrently administered once a day, retilin is parabulbary administered and cortexin and epithalamine are administered intramuscularly until therapeutic result is achieved. EFFECT: accelerated treatment course; improved vision function. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
| METHOD FOR TREATING DYSTROPHIC DISEASES OF EYES | 2000 |
|
RU2195297C2 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 2004 |
|
RU2270025C1 |
| METHOD OF TREATING PATIENTS WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY | 2011 |
|
RU2480252C1 |
| AGENT INHIBITING ANGIOGENESIS IN VISUAL ORGAN DISEASE | 2001 |
|
RU2177801C1 |
| METHOD OF TREATMENT OF GLAUCOMA OPTIC NEUROPATHY | 2006 |
|
RU2335283C2 |
| AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
| METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
| METHOD FOR ADMINISTERING MEDICAMENTS WHEN TREATING POSTERIOR EYE SEGMENT DISEASES | 2002 |
|
RU2199988C1 |
| PHARMACEUTICAL COMPOSITION ELICITING THROMBOLYTIC AND FIBRINOLYTIC EFFECT | 2002 |
|
RU2216348C1 |
